Cipla completes share allocation to FIL Capital Investments
An investment agreement was signed between both the companies for Cipla's consumer healthcare business in November 2015
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sun Pharma settles trademark litigation with Psyco Remedies
Post reaching the settlement, a joint request for compromise was filed by both companies before the Madras High Court, where they…
Pharma sector likely to report good growth for Q4 of last fiscal
According to a report in Centrum Broking, the domestic pharma market will gain from price increase, volume growth and new product…
Recipharm acquires stake in Nitin Lifesciences
Recipharm acquires 74 per cent of the shares for a purchase consideration of Rs 6,713 million on a cash and debt free basis
Dr Rao VSV Vadlamudi re-elected as President of IPA
He has a stint of over three decades in industry and academia
Sun Pharma receives US FDA approval for BromSite
First NSAID approved for prevention of ocular pain in patients undergoing cataract surgery
Manipal College of Pharmaceutical Sciences bags recognition from NIRF
MCOPS has been ranked as the top pharmacy college in the country
Pfizer calls off $160-billion merger with Allergan
The decision to call off the merger came after the US Treasury Department announced new rules to discourage mergers between US and…
DDCR in research collaboration with RBPL
To explore new possibilities in diabetes research
Lupin launches generic insomnia drug in the US
This is the first product launched from GAVIS pipeline with 180 days exclusivity
SciencebyDesign to host DELabCon 2016
The conference on design and engineering will be held in Mumbai on April 21, 2016
Trucking Cube bags Rs 100-cr investment from Agarwal Movers Group
Transportation in 'cubes' assures zero loss during transhipment; crucial for pharma and food shipments
Type 1 Diabetes may up epilepsy risk by three times: Study
Immune abnormalities, brain lesions, genetic factors and metabolic abnormalities are all potential causes for the link between…
Rusan Pharma launches R&D centre at Kandla SEZ
Rusan Pharma signs $20 million per annum deal with Brazil Health Ministry for smoking cessation programme
Government releases Indian IP Panorama
It seeks to increase awareness about IP among stakeholders in the SME sector, academia and researchers
Aurobindo Pharma gets US FDA nod for valganciclovir tabs
Valganciclovir tablets is an anti-viral used in the treatment of Cytomegalovirus (CMV) retinitis
Aurobindo Pharma received final…
Prices of 103 formulation packs to come down after NPPA cap
The new prices will be effective from today, NPPA said in a notification on its website
Zydus’ Nesher Pharma gets US FDA nod for dextroamphetamine IR tabs
The drug is used in treating nervous system disorders, in the US market
DRL in agreement with Eisai Co, Japan
Acquires rights to Investigational Anticancer Agent E7777 for US, Europe and certain emerging markets from Eisai
AstraZeneca’s Chennai-based GTC sees strong growth and momentum
In 2016, the centre will focus a lot on application development and testing, business intelligence and analytics, mobility and…